Remote Ischemic Conditioning and Platelet Dysfunction

April 2, 2019 updated by: Yunseok Jeon, Seoul National University Hospital

Effect of Remote Ischemic Conditioning on Platelet Dysfunction Following Off-pump Coronary Artery Bypass Surgery

The purpose of this study is to evaluate the effects of remote ischemic conditioning on platelet function during off-pump coronary artery bypass surgery.

Study Overview

Status

Completed

Conditions

Detailed Description

Remote ischemic conditioning (RIC) may affect platelet function. However, little is known about effect of RIC on platelet function during off-pump coronary artery bypass surgery. In this study investigators are going to perform RIC after anesthesia induction (remote ischemic pre-conditioning) and after completion of coronary anastomoses (remote ischemic post-conditioning), and compare platelet function parameters with control group.

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 20 - 80 years of adult patient undergoing elective off-pump coronary artery bypass surgery

Exclusion Criteria:

  • Acute Myocardial Infarction
  • Recent (<1 month) coronary angioplasty (percutaneous coronary intervention, PCI)
  • Acute cerebrovascular ischemia (<6 months)
  • Preoperative LV EF < 30%, mechanical ventricular support (IABP, VAD, ECMO)
  • Peripheral vascular disease
  • Poorly controlled diabetes mellitus
  • Alzheimer's disease
  • NSAIDs within 3 days
  • iv heparin within 6 h
  • low molecular weight heparin within 24 h
  • platelet inhibitor within 24 h
  • known thrombocytopenia
  • renal failure / hemodialysis
  • active infection
  • preoperative bleeding diathesis
  • redo-operation
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Remote ischemic conditioning
Applying pneumatic cuff on upper extremity (5 minutes cycles of limb ischemia and reperfusion with pneumatic cuff up to 200 mmHg repeated by four times) before and after coronary anastomoses.
In the RIC group, RIC is performed before and after coronary anastomoses by 5 minutes limb ischemia and reperfusion with pneumatic cuff up to 200 mmHg repeated by four times.
Placebo Comparator: Control
All the procedures were the same in the control group, except for the fact that the three-way stopcock between the pneumatic cuff and the cuff inflator was opened and therefore the cuff pressure did not increase.
In the control group, all the procedures will be same with RIC group, except for the fact that the three-way stopcock between the pneumatic cuff and the cuff inflator was opened and therefore the cuff pressure did not increase.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Multiplate ADPtest AUC
Time Frame: Baseline, at the end of surgery, postoperative day 1
Area under the aggregation curve (AUC) after platelet stimulation with adenosine diphosphate
Baseline, at the end of surgery, postoperative day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Multiplate ASPItest AUC
Time Frame: Baseline, at the end of surgery, postoperative day 1
Area under the aggregation curve (AUC) after platelet stimulation with arachidonic acid
Baseline, at the end of surgery, postoperative day 1
Change of Multiplate COLtest AUC
Time Frame: Baseline, at the end of surgery, postoperative day 1
Area under the aggregation curve (AUC) after platelet stimulation with collagen
Baseline, at the end of surgery, postoperative day 1
Change of Rotational thromboelastometry EXTEM parameter
Time Frame: Baseline, at the end of surgery, postoperative day 1
Screening test for the extrinsic haemostasis system
Baseline, at the end of surgery, postoperative day 1
Change of Rotational thromboelastometry FIBTEM parameter
Time Frame: Baseline, at the end of surgery, postoperative day 1
Represents an EXTEM based assay for the fibrin part of the clot
Baseline, at the end of surgery, postoperative day 1
Rotational thromboelastometry INTEM parameter
Time Frame: Baseline, at the end of surgery, postoperative day 1
Intrinsically activated rotational thrombelastometry
Baseline, at the end of surgery, postoperative day 1
Change of Rotational thromboelastometry HEPTEM parameter
Time Frame: Baseline, at the end of surgery, postoperative day 1
Represents an INTEM assay performed in the presence of heparinase
Baseline, at the end of surgery, postoperative day 1
Amount of peri-operative bleeding and transfusion
Time Frame: At the end of surgery, postoperative day 1,2,3
Amount of peri-operative bleeding and transfusion
At the end of surgery, postoperative day 1,2,3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yunseok Jeon, M.D., Ph. D., Seoul National University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 11, 2017

Primary Completion (Actual)

January 31, 2019

Study Completion (Actual)

February 9, 2019

Study Registration Dates

First Submitted

April 14, 2017

First Submitted That Met QC Criteria

April 18, 2017

First Posted (Actual)

April 24, 2017

Study Record Updates

Last Update Posted (Actual)

April 4, 2019

Last Update Submitted That Met QC Criteria

April 2, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RIPC_multiplate

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Platelet Function

Clinical Trials on Remote ischemic conditioning

3
Subscribe